As patients with lung cancer live longer, the risk of long-term cardiac side effects of radiation therapy has been increasing, despite advances that reduce the radiation dose to the heart. New research uses machine learning to mine data…
A year of treatment with a medicine made of an antibody and chemotherapy drug has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring in patients, a team led by Dana-Farber Cancer Institute researchers…
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for…
Patients with treatment-refractory cancers who received eligibility and testing waivers to participate in a large basket/umbrella oncology trial had similar rates of clinical benefit and adverse events as patients who participated in the…
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for…
A new study from Karolinska Institutet shows that 45 genes may play a crucial role in the prognosis of patients with adrenal cancer. The findings, published in the journal ESMO Open, give hope for a better diagnostic tool than is currently…
Researchers have identified a protein called PFDN6 that may play a role in the development and spread of colorectal cancer (CRC). The study, published in [journal name], found that PFDN6 levels are increased in CRC patients and contribute…
Despite significant improvements in data sharing for cancer clinical trials over the last 10 years, further changes are still needed to ensure patient-centered care, medical advancements, and trust in the pharmaceutical industry, say…
Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering patients better prospects for survival and quality of life, but a significant uptick in early-onset cases is raising new questions about…
The First Minister was asked to explain why 26,000 cancer patients have waited longer than the 62-day standard for beginning treatment over the decade.
What defines a true leader? Is it just the field victories, or does it go beyond that? Maybe it extends beyond that, touching lives in profound, personal ways. Ole Miss head coach Lane Kiffin recently showcased an exemplary model of…
Hackers behind a London hospital attack recently published records that include personal information about pregnant women, newborns, cancer patients, people suffering from schizophrenia and thousands of others across the UK and Ireland,…
I’m honored to have oncologist, Katie Deming MD on the podcast today. Here’s what we talk about in today’s episode: What we need to know about cancer that no one tells us Cancer’s multiple root systems Her 6 pillars to radiant health…
A discovery by researchers at the University of British Columbia promises to improve care for patients with endometrial cancer, the most common gynecologic malignancy.
Cancer patients will benefit from the investment but so will people with other health conditions because the funding also covers medicines that Pharmac ranked as more important.
A new study introduces an adaptive therapy approach that could optimize PARP inhibitor maintenance therapy, offering a more personalized and potentially less toxic treatment option for patients.